|
Index of reports
> Cases with Sepsis (129)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 129 Next >>
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male, weighing 77.2 kg (169.8 pounds)
Reactions: Sepsis, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
CC-4047
Dosage: 4 milligram
Administration route: Oral
Start date: 2012-05-04
End date: 2012-05-08
CC-4047
Dosage: 4 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-12
End date: 2012-04-16
CC-4047
Dosage: 2 milligram
Administration route: Oral
Start date: 2012-05-08
CC-4047
Dosage: 2 milligram
Administration route: Oral
Start date: 2012-04-27
Clarithromycin
Dosage: 1000 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-12
Dexamethasone
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-12
Revlimid
Dosage: 5 milligram
Administration route: Oral
Other drugs received by patient: Atenolol; Hydrocortisone; Omega-3 Fatty Acids; Potassium Chloride; Atorvastatin Calcium; Metformin HCL; Amlodipine; Vasotec; Glyburide; Zometa; Prilosec; Magnesium Oxide; Niaspan; Tylenol; Actos; Imodium; Valtrex; Aspirin; Darbepoetin Alfa-Polysorbate; Feosol; Hydrocortisone
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Hypoxia, Pleural Effusion
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Hypoxia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: male
Reactions: Pneumonia, Sepsis, Hypoxia, Mastoiditis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 4 mg, cyclic
Indication: Multiple Myeloma
Start date: 2012-04-04
Dexamethasone
Dosage: 4 mg, cyclic
Start date: 2012-05-01
Velcade
Dosage: 1.3 mg/m2, cyclic
Administration route: Oral
Start date: 2012-05-01
Velcade
Dosage: 1 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2012-04-04
Velcade
Dosage: 1.3 mg/m2, cyclic
Start date: 2012-04-04
Other drugs received by patient: Epogen; Neupogen; Blood and Related Products; Levaquin; Lithium Carbonate; Amitriptyline HCL; Platelets; Vfend; Acyclovir; Androderm
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Dexamethasone side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-10
Patient: 73 year old female
Reactions: Neutropenic Sepsis, Sepsis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-26
End date: 2012-07-26
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-26
End date: 2012-07-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-26
End date: 2012-07-01
Possible Dexamethasone side effects in female
Reported by a physician from United Kingdom on 2012-08-07
Patient: female
Reactions: Sepsis, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-22
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-20
Possible Dexamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: male
Reactions: Neutropenic Infection, Fungal Infection, Sepsis, Bacterial Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: male
Reactions: Fungal Infection, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 3
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 4
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 2
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 2
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 3
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 4
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4
Rituximab
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3
Rituximab
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2
Rituximab
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1
Possible Dexamethasone side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: last dose on 16jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cytarabine
Dosage: last dose:17jun12 route:intra ommya
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Dexamethasone
Dosage: last dose:16jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Doxorubicin HCL
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Filgrastim
Dosage: last dose:18jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
End date: 2012-01-01
Leucovorin Calcium
Dosage: last dose :21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Mesna
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methotrexate
Dosage: last dose:13jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methylprednisolone
Dosage: last dose:21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Sprycel
Dosage: last dose on 26jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Vincristine Sulfate
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Possible Dexamethasone side effects in 70 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-19
Patient: 70 year old male
Reactions: Sepsis, Urinary Tract Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Start date: 2012-03-14
End date: 2012-07-06
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Start date: 2012-03-14
End date: 2012-07-06
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-03-14
End date: 2012-07-06
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-18
Patient: male
Reactions: Neutropenic Infection, Fungal Infection, Sepsis, Bacterial Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: male
Reactions: Fungal Infection, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 1
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 2
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 3
Chlorambucil
Dosage: from day 20 to 29 of each 35 days cycle, cycle 4
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 1
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 3
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 2
Dexamethasone
Dosage: from day 1 to 4 of each 35 days cycle, cycle 4
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 3
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 1
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 2
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4 each cycle of 35 days, cycle 4
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 2
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 3
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 1
Indication: Mantle Cell Lymphoma
Rituxan
Dosage: on day 1 (day 8 of cycle 1) each cycle of 35 days, cycle 4
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 2
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 4
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 3
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11 each cycle of 35 days, cycle 1
Possible Dexamethasone side effects in male
Reported by a physician from Canada on 2012-07-16
Patient: male, weighing 68.9 kg (151.6 pounds)
Reactions: Multi-Organ Failure, Lung Infection, Sepsis, Muscular Weakness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-06
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-04-20
Other drugs received by patient: Gabapentin; Metoprolol Tartrate; Acyclovir; Sevelamer; Combigan; Amiodarone HCL; Vancomycin; Lumigan
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-16
Patient:
Reactions: Multi-Organ Failure, Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytoxan
Administration route: Oral
Indication: Amyloidosis
Dexamethasone
Administration route: Oral
Indication: Amyloidosis
Lenalidomide
Administration route: Oral
Indication: Amyloidosis
Possible Dexamethasone side effects in female
Reported by a physician from United Kingdom on 2012-07-16
Patient: female
Reactions: Sepsis, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-22
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-21
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-20
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-07-16
Patient:
Reactions: Pulmonary Toxicity, Gastrointestinal Toxicity, Nephropathy Toxic, Anaemia, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Sepsis, Cardiotoxicity, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: drug: ps 341 on d1, 4, 8 and 11 of cycle 1.
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: d20 to d29. one cycle every 35 days.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4.
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: continuous infusion for 4 days. form: infusion.
Indication: Mantle Cell Lymphoma
Mabthera
Dosage: day 1 (and day 8 for cycle 1).
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in female
Reported by a lawyer from United States on 2012-07-02
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-02
Patient:
Reactions: Anaemia, Pulmonary Embolism, Sudden Death, Rash, Macular Oedema, Cardiac Disorder, Fatigue, Sepsis, Cardiac Arrest, Thrombocytopenia, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Dexamethasone
Dosage: 5.7143 milligram
Revlimid
Administration route: Oral
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-26
Patient: male, weighing 68.0 kg (149.7 pounds)
Reactions: Humerus Fracture, Small Intestinal Obstruction, Dyspnoea, Tendon Rupture, Sepsis, Urinary Retention
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Velcade
Dosage: 2.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-02-14
End date: 2011-02-24
Other drugs received by patient: Cymbalta; Percocet; Wellbutrin; Advair Diskus 100 / 50; Centrum Silver / 01292501 /; Clonazepam; Calcium with Vitamin D / 00944201 /; Nexium; Aspirin; Lunesta; Magnesium Sulfate; Crestor; Oxycontin; Senna / 00142201 /; Proventil / 00139501 /
Possible Dexamethasone side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22
Patient: 67 year old male
Reactions: Sepsis, Pulmonary Oedema, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-30
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-30
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-30
Possible Dexamethasone side effects in female
Reported by a physician from United States on 2012-06-21
Patient: female, weighing 50.4 kg (110.9 pounds)
Reactions: Abdominal Pain Lower, Vomiting, Diarrhoea, Nausea, Sepsis, Ventricular Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-01-24
End date: 2012-03-13
Other drugs received by patient: Benazepril Hydrochloride; Ferrous Fumarate; Simvastatin; Amlodipine; Iron; Calcium; Aspirin; Cytoxan
Possible Dexamethasone side effects in female
Reported by a physician from United States on 2012-06-14
Patient: female, weighing 50.4 kg (110.9 pounds)
Reactions: Abdominal Pain Lower, Vomiting, Nausea, Diarrhoea, Sepsis, Ventricular Tachycardia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-01-24
End date: 2012-03-13
Other drugs received by patient: Benazepril Hydrochloride; Simvastatin; Calcium; Iron; Ferrous Fumarate; Cytoxan; Amlodipine; Aspirin
Possible Dexamethasone side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-12
Patient: 67 year old male
Reactions: Sepsis, Pulmonary Oedema, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-30
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-30
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-30
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from Denmark on 2012-06-01
Patient:
Reactions: Neurotoxicity, Death, Sepsis, Haematotoxicity
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Central Nervous System Lymphoma
Cytarabine
Cytarabine
Indication: Central Nervous System Lymphoma
Dexamethasone
Indication: Central Nervous System Lymphoma
Ifosfamide
Indication: Central Nervous System Lymphoma
Mabthera
Indication: Central Nervous System Lymphoma
Methotrexate
Indication: Central Nervous System Lymphoma
Temozolomide
Indication: Central Nervous System Lymphoma
Vincristine
Indication: Central Nervous System Lymphoma
Vindesine
Indication: Central Nervous System Lymphoma
Page 1 Next >>
|
